Please login to access the CRTOnline Presentations.
CeloNova Enrolls First Patient in COBRA REDUCE Trial for Patients at High Risk of Bleeding
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details